Salubris Pharmaceuticals Ltd. Tech Stack

Integrated pharma manufacturer spanning APIs, formulations, and specialty medicines

Pharmaceutical Manufacturing Futian District, Shenzhen, Guangdong 1,001–5,000 employees Founded 1998 Public Company

Salubris operates a vertically integrated pharmaceutical manufacturing footprint across active pharmaceutical ingredients, finished dosage forms (tablets, capsules, injections), and specialty therapeutics. The tech stack reflects GMP-regulated operations: HPLC, gas chromatography, LIMS, MES, and DCS systems for process control—paired with clinical trial management (Medidata Rave, CDISC) and SAS for analytics. Hiring velocity is minimal across a sales-led org (44 sales roles vs. 18 research), signaling mature commercial execution rather than early-stage R&D expansion.

Tech Stack 15 technologies

Core StackPython SAS HPLC LIMS MES DCS PLC PowerPoint CDISC Word Excel Medidata Rave WPS Office Gas Chromatography

What Salubris Pharmaceuticals Ltd. Is Building

◆Challenges

Verification process management
Optimizing experimental conditions
Ensuring timely execution
Managing reagent procurement
Csv gap analysis
Compliance with gmp
Risk assessment and deviation handling
Managing trial documentation
Tracking vendor payments
Tracking trial material distribution

▲Active Projects

Product promotion in target hospitals
Build and maintain local expert network
Instrument maintenance and cell room management
Process transfer and scale-up project
Product market positioning and annual promotion plan
New product market research
Academic conference organization
Deviation and change management
Kol relationship maintenance
Establish local expert network

Hiring Activity

Minimal85 roles · 10 in 30d

Department

Sales

Research

Manufacturing

Engineering

Marketing

Data

Legal

Ops

Seniority

Mid

Junior

Intern

Manager

Senior

Company intelligence

Find more companies like Salubris Pharmaceuticals Ltd. by tech stack, pain points and active projects

Get started free

About Salubris Pharmaceuticals Ltd.

Salubris is a publicly traded pharmaceutical group headquartered in Shenzhen with 1,001–5,000 employees, founded in 1998. The company manufactures and distributes across three therapeutic pillars: cardiovascular and interventional medical devices, antibiotics, and biopharmaceuticals. Operations include GMP-certified manufacturing facilities producing tablets, capsules, injections, and active ingredients, supported by subsidiary branches and a national marketing network. Active projects center on hospital relationships, KOL networks, process transfer and scale-up, and market positioning—typical of a mid-market incumbent managing portfolio maturity and regulatory compliance.

HeadquartersFutian District, Shenzhen, Guangdong

Company Size1,001–5,000 employees

Founded1998

Hiring MarketsChina

Frequently Asked Questions

What manufacturing processes does Salubris operate?

Salubris produces tablets, capsules, and injection formulations, as well as active pharmaceutical ingredients (APIs). Facilities are GMP-certified and employ HPLC, gas chromatography, LIMS, MES, and DCS systems for process control and quality assurance.

What therapeutic areas does Salubris focus on?

Salubris specializes in cardiovascular medicine, interventional medical devices, antibiotics, and biopharmaceuticals, marketed through its national subsidiary and distribution network.